News

Brain injury survivors help shape new medical technologies

4 June 2025

Researchers based at Cambridge University Hospitals NHS Foundation Trust (CUH) have developed a programme to ensure that the development of medical technology is in line with the unmet needs of brain injury survivors. The programme was developed by James Piercy, an “expert by experience” of brain injury. James suffered a...

Mina Ryten elected as Academy of Medical Sciences fellow

22 May 2025

We are delighted to announce that Professor Mina Ryten, Centre Director for the UK DRI at Cambridge, has been elected as one of 54 exceptional biomedical and health scientists to the prestigious Academy of Medical Sciences Fellowship. Professor Ryten commented: “I’m deeply honoured to be elected to the Academy of Medical...

Breakthrough for Global Movement to recognise Traumatic Brain Injury

20 May 2025

GENEVA, SWITZERLAND – In a significant advance for global health policy, the Ministry of Health of Pakistan has confirmed its official sponsorship of a ground-breaking resolution to recognize Traumatic Brain Injury (TBI) as a chronic, notifiable global health condition. "TBI is a global public health crisis hidden in plain...

New paper explores gut dysfunction in Parkinson’s

20 May 2025

Marta Camacho from the Williams-Gray lab has published a new paper defining the characteristics of gut dysfunction in Parkinson's disease. The role of gut dysfunction and its links to neurodegeneration is a very topical issue, with wide interest from both researchers and the media. In this Q&A Marta explains her...

Metabolic driver of Parkinson’s offers new target for treatment

30 April 2025

Researchers led by Dr Sung Min Son and Prof David Rubinsztein (UK DRI at Cambridge) have identified a key enzyme driving forms of Parkinson’s, and have shown how blocking it restores normal function in animal and cell models – offering a promising new drug target for the condition. In Parkinson’s, a protein known as alpha-...

Stefano Pluchino receives Experimental Medicine Trial Award from the International Progressive MS Alliance

29 April 2025

This international award has gone to three development projects in Canada and the United Kingdom, which will each receive €100,000 to begin planning for future clinical trials. Dr. Stefano Pluchino’s team is one of three projects to have received funding for clinical trial development projects as part of the International...

World-first trial indicates immunosuppression may help treat Parkinson's

23 April 2025

A groundbreaking trial, led from Cambridge, has revealed that immunosuppressing medicines show promise for the treatment of Parkinson’s disease, according to results presented this weekend at the world’s most prestigious neurodegeneration conference AD/PD. This trial is the first to show that broadly suppressing the immune...

Powerful new MRI scans enable life-changing surgery in first for adults with epilepsy

25 March 2025

Scientists have developed a new technique that has enabled ultra-powerful magnetic resonance imaging (MRI) scanners to identify tiny differences in patients’ brains that cause treatment-resistant epilepsy. It has allowed doctors at Addenbrooke’s Hospital, Cambridge, to offer the patients surgery to cure their condition...

First global pituitary study gives patients voice on research

20 March 2025

155 patients, carers and healthcare professionals across 14 countries identified their top 10 questions for researchers. Researchers from Cambridge and London have completed a study that is a world first of its kind and gives patients an important voice on future priorities. It was led by Angelos Kolias, Consultant...

Prestigious MRC Fellowship awarded to revolutionize microglia metabolism research and find groundbreaking treatments for cognitive decline in multiple sclerosis

14 March 2025

Dr. Luca Peruzzotti-Jametti of the Department of Clinical Neurosciences, University of Cambridge, has been awarded a prestigious MRC Clinician Scientist Fellowship. This £2 million, five-year grant will fund research to fundamentally reshape our understanding of neuroinflammation and cognitive decline in conditions such as...

Brain injury survivors help shape new medical technologies

Mina Ryten elected as Academy of Medical Sciences fellow

Breakthrough for Global Movement to recognise Traumatic Brain Injury

New paper explores gut dysfunction in Parkinson’s

Metabolic driver of Parkinson’s offers new target for treatment

Stefano Pluchino receives Experimental Medicine Trial Award from the International Progressive MS Alliance

World-first trial indicates immunosuppression may help treat Parkinson's

Powerful new MRI scans enable life-changing surgery in first for adults with epilepsy

First global pituitary study gives patients voice on research

Prestigious MRC Fellowship awarded to revolutionize microglia metabolism research and find groundbreaking treatments for cognitive decline in multiple sclerosis

Join us online

li_blue.png

bsky_blue.png

Study at Cambridge

About the University

Research at Cambridge